Chronobiology and Enteral Nutrition
Chronobiology and Chronodisruption in People Receiving Medical Nutritional Therapy and Its Impact on the Quality of Life of Patients and Caregivers. A Descriptive and Interventional Study. Chronumet.
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
60 participants
Oct 10, 2025
INTERVENTIONAL
Conditions
Summary
Medical Nutritional Therapy (MNT) is critical for patients with impaired oral intake and is typically administered via enteral nutrition (EN). Current infusion practices-continuous 24-hour enteral nutrition for hospitalised patients-may induce circadian misalignment (chronodisruption). This misalignment can negatively impact metabolic function, sleep quality, and overall quality of life for both patients and caregivers. Synchronising MNT administration with circadian rhythms may improve metabolic balance, sleep, and patient well-being. Hypothesis: The timing of the administration of Medical Nutritional Therapy via continuous enteral nutrition (EN) in hospitalised patients may induce chronodisruption in biological rhythms (clock genes). This disruption can affect the metabolism of carbohydrates, lipids, and proteins, contributing to morbidity and altering chronotype, quality of life, and sleep patterns.
Eligibility
Inclusion Criteria4
- Use of enteral nutrition (EN) for 15 days or more. Participants must be from the Regional University Hospital of Málaga (HRUM), Virgen del Rocío Hospital of Seville (HVR), Reina Sofía University Hospital of Córdoba, or the NUPA Association.
- Participants must not have experienced acute metabolic decompensation in the last 7 days.
- Participants must be able to answer the questionnaires with or without family support.
- Participants must provide informed consent (patient or legal representative).
Exclusion Criteria3
- Pregnancy
- Use of melatonin for sleep.
- Uncontrolled psychiatric condition.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients Receiving EN Daytime-restricted EN (9 AM to 9 PM for 4 days).
Hospitalised Patients Receiving EN: 24-hour EN + Melatonin (0.5 mg sublingual at 8 PM).
Hospitalised Patients Receiving EN: 24-hour EN + Placebo (sublingual at 8 PM).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07554716